Comment by
QContinuum1 on Jun 04, 2024 12:46pm
Most interesting is that the primary enddate of the trial is Sept of 2024. Probably looking at a Q or two more before the study results are formalized and released but still, a very advanced study for a compound that LABS is known to supply. Potentially very big deal this.